63
Participants
Start Date
September 30, 2007
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%]
Nabi-IGIV 10% \[Immune Globulin Intravenous (Human), 10%\] is a clear or slightly opalescent, colorless to pale yellow sterile solution of 10% protein concentration of immunoglobulin G (100mg/mL). It is packaged as 5g in 50mL solution and 10g in 100mL solution. Dosing will be 300-800 mg/kg based on subject's prior dosing history. Infusions will be every 3 or 4 weeks.
Women's and Children's Hospital of Buffalo, Buffalo
Institute For Allergy & Asthma, Wheaton
Marietta Pulmonary Medicine, Marietta
Allergy Associates of the Palm Beaches, North Palm Beach
University of Alabama, Birmingham
Kentuky Lung Clinic, PSC, Hazard
University Hospital Case medical center, Cleveland
South Bend Clinic LLP, South Bend
Rush University Medical center, Chicago
Cardinal Glennon Children's MC, St Louis
Allergy, Asthma & Immunology Clinic, PA, Irving
Allergy/Immunology Research Center of north Texas, Dallas
AARA Research, Dallas
1st Allergy and Clinical Resaerch center, Centennial
Precision Trials LLC, Phoenix
Children's Hospital of Los Angeles, Los Angeles
Bellingham Asthma, Allergy Clinic, Bellingham
Lead Sponsor
ADMA Biologics, Inc.
INDUSTRY